Literature DB >> 27429314

In insulin-treated type 1 diabetes, canagliflozin increased diabetic ketoacidosis.

Jad G Sfeir, Victor M Montori.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27429314     DOI： 10.7326/ACPJC-2016-165-2-002

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  2 in total

1.  Euglycemic ketosis in patients with type 2 diabetes on SGLT2-inhibitor therapy-an emerging problem and solutions offered by diabetes technology.

Authors:  A Pfützner; D Klonoff; L Heinemann; N Ejskjaer; J Pickup
Journal:  Endocrine       Date:  2017-03-17       Impact factor: 3.633

Review 2.  Sodium-glucose co-transporter inhibitors as adjunctive treatment to insulin in type 1 diabetes: A review of randomized controlled trials.

Authors:  Schafer Boeder; Steven V Edelman
Journal:  Diabetes Obes Metab       Date:  2019-04       Impact factor: 6.577
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.